Horio, H., & Ohtsuru, M. (2001). Maitake (Grifola frondosa) improve glucose tolerance of experimental diabetic rats. Journal of nutritional science and vitaminology, 47(1), 57–63. https://doi.org/10.3177/jnsv.47.57

Kubo, K., Aoki, H., & Nanba, H. (1994). Anti-diabetic activity present in the fruit body of Grifola frondosa (Maitake). I. Biological & pharmaceutical bulletin, 17(8), 1106–1110. https://doi.org/10.1248/bpb.17.1106

Chen, Y., Liu, D., Wang, D., Lai, S., Zhong, R., Liu, Y., Yang, C., Liu, B., Sarker, M. R., & Zhao, C. (2019). Hypoglycemic activity and gut microbiota regulation of a novel polysaccharide from Grifola frondosa in type 2 diabetic mice. Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association, 126, 295–302. https://doi.org/10.1016/j.fct.2019.02.034

Harada, E., Morizono, T., Kanno, T., Saito, M., & Kawagishi, H. (2020). Medicinal Mushroom, Grifola gargal (Agaricomycetes), Lowers Triglyceride in Animal Models of Obesity and Diabetes and in Adults with Prediabetes. International journal of medicinal mushrooms, 22(1), 79–91. https://doi.org/10.1615/IntJMedMushrooms.2019033285

Kanetkar, P., Singhal, R., & Kamat, M. (2007). Gymnema sylvestre: A Memoir. Journal of clinical biochemistry and nutrition, 41(2), 77–81. https://doi.org/10.3164/jcbn.2007010

Diabetes in control (2001). Effect of extended release gymnema sylvestre leaf extract (beta fast GXR) along or in combination with oral hypoglycemics or insulin regimens for type 1 and type 2 diabetes. Diabetes in Control Newsletter. 76(1). Retrieved from https://www.diabetesincontrol.com/effect-of-extended-release-gymnema-sylvestre-leaf-extract-beta-fast-gxr/

Tiwari, P., Ahmad, K., & Baig, M. H. (2017). Gymnema sylvestre for Diabetes: From Traditional Herb to Future’s Therapeutic. Current pharmaceutical design, 23(11), 1667–1676. https://doi.org/10.2174/1381612823666161108162048

Pothuraju, R., Sharma, R. K., Chagalamarri, J., Jangra, S., & Kumar Kavadi, P. (2014). A systematic review of Gymnema sylvestre in obesity and diabetes management. Journal of the science of food and agriculture, 94(5), 834–840. https://doi.org/10.1002/jsfa.6458

Stohs, S. J., & Ray, S. (2015). Anti-diabetic and Anti-hyperlipidemic Effects and Safety of Salacia reticulata and Related Species. Phytotherapy research : PTR, 29(7), 986–995. https://doi.org/10.1002/ptr.5382

Moazezi, Z., & Qujeq, D. (2014). Berberis Fruit Extract and Biochemical Parameters in Patients With Type II Diabetes. Jundishapur journal of natural pharmaceutical products, 9(2), e13490. https://doi.org/10.17795/jjnpp-13490

Habicht, S., Ludwig, C., et al. (2014). Momordica charantia and Type 2 diabetes: From in vitro to human studies. Current Diabetes Reviews. 10(1), 48-60. 10.2174/1573399809666131126152044

Fuangchan, A., Sonthisombat, P., et al. (2011). Hypoglycemic effect of bitter melon compared with metformin in newly diagnosed type 2 diabetes patients. Journal of Ethnopharmacology. 134(2): 422-428. https://doi.org/10.1016/j.jep.2010.12.045

Md Ashraful Alam, Riaz Uddin, Nusrat Subhan, Md Mahbubur Rahman, Preeti Jain, Hasan Mahmud Reza, “Beneficial Role of Bitter Melon Supplementation in Obesity and Related Complications in Metabolic Syndrome”, Journal of Lipids, vol. 2015, Article ID 496169, 18 pages, 2015. https://doi.org/10.1155/2015/496169

Towler, M. & Hardie, G. (2007). AMP-Activated protein kinase in metabolic control and insulin signaling. Circulation Research. 100: 328-341. https://doi.org/10.1161/01.RES.0000256090.42690.05

Ilyas, Z., Perna, S., et al. (2020). The effect of berberine on weight loss in order to prevent obesity: A systematic review. Biomedicine & Pharmacotherapy. 127: 110137. https://doi.org/10.1016/j.biopha.2020.110137

Chang, W., Chen, L., & Hatch, G. M. (2015). Berberine as a therapy for type 2 diabetes and its complications: From mechanism of action to clinical studies. Biochemistry and cell biology = Biochimie et biologie cellulaire, 93(5), 479–486. https://doi.org/10.1139/bcb-2014-0107

Yin, J., Xing, H., & Ye, J. (2008). Efficacy of berberine in patients with type 2 diabetes mellitus. Metabolism: clinical and experimental, 57(5), 712–717. https://doi.org/10.1016/j.metabol.2008.01.013

Li, M. F., Zhou, X. M., & Li, X. L. (2018). The Effect of Berberine on Polycystic Ovary Syndrome Patients with Insulin Resistance (PCOS-IR): A Meta-Analysis and Systematic Review. Evidence-based complementary and alternative medicine : eCAM, 2018, 2532935. https://doi.org/10.1155/2018/2532935

Interested in Gluco-DB? Learn More